H

Hyundai Bioscience Co Ltd
KOSDAQ:048410

Watchlist Manager
Hyundai Bioscience Co Ltd
KOSDAQ:048410
Watchlist
Price: 14 670 KRW 1.24% Market Closed
Market Cap: 584.1B KRW
Have any thoughts about
Hyundai Bioscience Co Ltd?
Write Note

Operating Margin
Hyundai Bioscience Co Ltd

-88.5%
Current
-167%
Average
5.5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-88.5%
=
Operating Profit
-8.2B
/
Revenue
9.2B

Operating Margin Across Competitors

Country KR
Market Cap 584.1B KRW
Operating Margin
-89%
Country FR
Market Cap 177.9B EUR
Operating Margin
19%
Country UK
Market Cap 118B GBP
Operating Margin
18%
Country IN
Market Cap 5.8T INR
Operating Margin
22%
Country UK
Market Cap 34.5B GBP
Operating Margin
19%
Country DE
Market Cap 27.8B EUR
Operating Margin
11%
Country US
Market Cap 27.2B USD
Operating Margin
10%
Country JP
Market Cap 3T JPY
Operating Margin
7%
Country IN
Market Cap 1.3T INR
Operating Margin
21%
Country IN
Market Cap 935.5B INR
Operating Margin
15%
Country US
Market Cap 10.1B USD
Operating Margin
19%
No Stocks Found

Hyundai Bioscience Co Ltd
Glance View

Market Cap
584.1B KRW
Industry
Consumer products

HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.

Intrinsic Value
501.94 KRW
Overvaluation 97%
Intrinsic Value
Price
H

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-88.5%
=
Operating Profit
-8.2B
/
Revenue
9.2B
What is the Operating Margin of Hyundai Bioscience Co Ltd?

Based on Hyundai Bioscience Co Ltd's most recent financial statements, the company has Operating Margin of -88.5%.